|
Case Name |
Date Filed |
Judge |
Drug |
Patent No(s). |
|
Teva Pharma. USA Inc. v. Synthon Pharma., Inc., 12-2556 (S.D.N.Y.) |
Apr. 3, 2012 |
Hon. Barbara S. Jones |
Copaxone®(glatiramer acetate injection) |
7,199,098 6,939,539 6,054,430 6,620,847 5,981,589 6,342,476 6,362,161 |
|
AR Holding Co., Inc. v. Par Pharma., Inc., 12-0419 (D. Del.) |
Apr. 4, 2012 |
Hon. Mary Pat Thynge |
Colcrys®(colchicine USP) |
7,619,004 7,601,758 7,820,681 7,915,269 7,964,647 7,964,648 7,981,938 8,093,296 8,093,297 8,097,655 |
|
Teva Pharma. USA, Inc. v. Synthon Pharma., Inc., 12-0179 (E.D.N.C.) |
Apr. 4, 2012 |
Hon. James C. Dever, III |
Copaxone®(glatiramer acetate injection) |
7,199,098 6,939,539 6,054,430 6,620,847 5,981,589 6,342,476 6,362,161 |
|
Allergan Sales, LLC v. Akorn, Inc., 12-0175 (E.D. Tex.) |
Apr. 4, 2012 |
Hon. Rodney Gilstrap |
Acular LS®(ketorolac tromethamine ophthalmic solution, 0.4%) |
8,008,338 |
|
Allergan Sales, LLC v. Alcon Research, Ltd., 12-0177 (E.D. Tex.) |
Apr. 4, 2012 |
Hon. Rodney Gilstrap |
Acular LS®(ketorolac tromethamine ophthalmic solution, 0.4%) |
8,008,338 |
|
Allergan Sales, LLC v. Apotex, Inc., 12-0178 (E.D. Tex.) |
Apr. 4, 2012 |
Hon. Rodney Gilstrap |
Acular LS®(ketorolac tromethamine ophthalmic solution, 0.4%) |
8,008,338 |
|
Sanofi-Aventis U.S. LLC v. Strides, Inc., 12-2070 (D.N.J.) |
Apr. 5, 2012 |
Hon. Joel A. Pisano |
Eloxatin®(oxaliplatin injection) |
5,338,874 5,716,988 |
|
Abbott Labs. v. Roxane Labs., Inc., 12-0457 (D. Del.) |
Apr. 10, 2012 |
Hon. Christopher J. Burke |
Norvir®(ritonavir tablets) |
7,148,359 7,364,752 5,648,497 |
|
Depomed, Inc. v. Impax Labs., Inc., 12-2154 (D.N.J.) |
Apr. 10, 2012 |
Hon. Joel A. Pisano |
Gralise®(gabapentin tablets) |
6,340,475 6,488,962 6,635,280 6,723,340 7,438,927 7,731,989 |
|
Roxane Labs., Inc., v. Abbott Labs., 12-0312 (S.D. Ohio) |
Apr. 10, 2012 |
Hon. Michael H. Watson |
Norvir®(ritonavir tablets) |
7,148,359 7,364,752 |
|
Purdue Pharma L.P. v. Varam, Inc., 12-2814 (S.D.N.Y.) |
Apr. 10, 2012 |
Hon. Sidney H. Stein |
OxyContin®(oxycodone hydrochloride extended release tablets) |
5,508,042 7,674,799 7,674,800 7,683,072 |
|
AstraZeneca Pharma. LP v. IntelliPharmaCeutics Corp., 12-2855 (S.D.N.Y.) |
Apr. 11, 2012 |
Hon. Richard J. Sullivan |
Seroquel XR®(quetiapine fumurate extended release tablets) |
5,948,437 |
|
UCB, Inc. v. Mallinckrodt, Inc., 12-0463 (D. Del.) |
Apr. 12, 2012 |
Hon. Leonard P. Stark |
Metadate CD®(methylphenidate hydrochloride capsules) |
6,344,215 |
|
Purdue Pharma L.P. v. Varam, Inc., 12-1898 (E.D. Pa.) |
Apr. 12, 2012 |
Hon Petrese B. Tucker |
OxyContin®(oxycodone hydrochloride extended release tablets) |
5,508,042 7,674,799 7,674,800 7,683,072 |
|
Osi Pharma., LLC v. Roxane Labs., Inc., 12-0465 (D. Del.) |
Apr. 13, 2012 |
Hon. Sue L. Robinson |
Tarceva®(erlotinib hydrochloride tablets) |
RE41,065 6,900,221 7,087,613 |
|
Pfizer, Inc. v. Dr. Reddy’s Labs., Ltd., 12-0467 (D. Del.) |
Apr. 13, 2012 |
Hon. Leonard P. Stark |
Caduet®(amlodipine besylate and atorvastatin calcium tablets) |
6,455,574 |
|
Allergan, Inc. v. Sandoz, Inc., 12-0207 (E.D. Tex.) |
Apr. 13, 2012 |
Hon. Rodney Gilstrap |
Combigan®(brimonidine tartrate/timolol maleate ophthalmic solution, 0.2%/0.5%) |
8,133,890 |
|
Purdue Pharma L.P. v. Mylan Pharma. Inc., 12-2959 (S.D.N.Y.) |
Apr. 13, 2012 |
Hon. Sidney H. Stein |
OxyContin®(oxycodone hydrochloride extended release tablets) |
7,674,799 7,674,800 7,683,072 |
|
Eli Lilly & Co. v. Apotex, Inc. 12-0499 (S.D. Ind.) |
Apr. 17, 2012 |
Hon. Jane Magnus-Stinson |
Alimta®(pemetrexed disodium injection) |
7,772,209 |
|
Depomed, Inc. v. Watson Labs., Inc. - Florida, 12-0492 (D. Del.) |
Apr. 18, 2012 |
Hon. Sue L. Robinson |
Glumetza®(metformin hydrochloride extended release tablets) |
6,488,962 7,780,987 |
|
Genzyme Corp. v. InvaGen Pharma., Inc., 12-1931 (E.D.N.Y.) |
Apr. 19, 2012 |
Hon. Margo K. Brodie |
Renvela®(sevelamer carbonate tablets ) |
5,667,775 |
|
Purdue Pharma L.P. v. Watson Labs., Inc. – Florida, 12-3111 (S.D.N.Y.) |
Apr. 19, 2012 |
Hon. Sidney H. Stein |
OxyContin®(oxycodone hydrochloride extended release tablets) |
8,114,383 |
|
Apotex, Inc. v. Mylan Pharma., Inc., 12-60704 (S.D. Fla.) |
Apr. 20, 2012 |
Hon. Kathleen M. Willia ms |
Quinapril (quinapr il hydrochloride and hydrochlorothiazide) |
6,531,486 |
|
Apotex, Inc. v. Mylan Pharma., Inc., 12-60704 (S.D. Fla.) |
Apr. 20, 2012 |
Hon. Kathleen M. Williams |
quinapril hydrochloride quinipril hydrochloride and hydrochlorothiazide |
6,531,486 |
|
Apotex, Inc. v. Pfizer, Inc., 12-60705 (S.D. Fla.) |
Apr. 20, 2012 |
Hon. K. Michael Moore |
Accupril®(quinapril) Accuretic®(hydrochlorothiazide and quinapril) |
6,531,486 |
|
Apotex, Inc. v. UCB, Inc., 12-60706 (S.D. Fla.) |
Apr. 20, 2012 |
Hon. Kathleen M. Williams |
Univasc®(moexipril) Uniretic®(moexipril HCl and hydrochlorothiazide) |
6,767,556 |
|
Apotex, Inc. v. Paddock Labs., Inc., 12-60707 (S.D. Fla.) |
Apr. 20, 2012 |
Hon. K. Michael Moore |
moexipril moexipril HCl and hydrochlrorthiazide |
6,767,556 |
|
Apotex, Inc. v. Lupin Pharma., Inc., 12-60708 (S.D. Fla.) |
Apr. 20, 2012 |
Hon. Donald M. Middlebrooks |
quinapril hydrochloride |
6,531,486 |
|
Genzyme Corp. v. Cobrek Pharma., Inc., 12-2937 (N.D. Ill.) |
Apr. 20, 2012 |
Hon. Milton I. Shadur |
Hectorol®(doxercalciferol injection) |
5,602,116 |
|
Osi Pharma., LLC v. Roxane Labs., Inc., 12-2384 (D.N.J.) |
Apr. 20, 2012 |
Hon. Dennis M. Cavanaugh |
Tarceva®(erlotinib hydrochloride tablets) |
RE41,065 6,900,221 7,087,613 |
|
Bayer Pharma AG v. Watson Pharma., Inc., 12-0517 (D. Del.) |
Apr. 25, 2012 |
Hon. Gregory M. Sleet |
Staxyn®(vardenafil HCl orally disintegrating tablets) |
6,362,178 7,696,206 |
|
Abbott Labs. V. Agila Specialties Private Ltd., 12-0520 (D. Del.) |
Apr. 25, 2012 |
Hon. Gregory M. Sleet |
Zemplar®(paricalcitol injection) |
6,136,799 6,361,758 5,597,815 |
|
Orion Corp. v. Mylan Pharma., Inc., 12-0523 (D. Del.) |
Apr. 26, 2012 |
Hon. Gregory M. Sleet |
Stalevo®(carbidopa, levodopa, and entacapone tablets) |
5446194 6500867 6797732 |
|
Warner Chilcott Co., LLC v. Ranbaxy, Inc., 12-2474 (D.N.J.) |
Apr. 26, 2012 |
Hon. Faith S. Hochberg |
Atelvia®(risedronate sodium delayed release tablets) |
7,645,459 7,645,460 |
|
Otsuka Pharma. Co., Ltd. v. Amneal Pharma., LLC, 12-2487 (D.N.J.) |
Apr. 26, 2012 |
Hon. Mary L. Cooper |
Abilify®(aripiprazole oral solution) |
6,977,257 |
|
Teva Neuroscience, Inc. v. Sandoz Inc., 12-2494 (D.N.J.) |
Apr. 26, 2012 |
Hon. Claire C. Cecchi |
Azilect®(rasagiline mesylate tablets) |
5,453,446 |
|
Valeant International (Barbados) SRL v. Sandoz, Inc., 12-0536 (D. Del.) |
Apr. 30, 2012 |
Hon. Sherry R. Fallon |
Aplenzin®(bupropion hydrobromide extended release tablets) |
7,241,805 7,569,610 7,572,935 7,585,897 7,645,802 7,649,019 7,662,407 7,671,094 7,553,992 |
|
Shire Development LLC v. Watson Pharma., Inc., 12-60862 (S.D. Fla.) |
May 8, 2012 |
Hon. Donald M. Middlebrooks |
Lialda®(mesalamine delayed release tablets) |
6,773,720 |
|
Depomed, Inc. v. Zydus Pharma. (USA), Inc., 12-2813 (D.N.J.) |
May 9, 2012 |
Hon. Joel A. Pisano |
Gralise®(gabapentin tablets) |
6,340,475 6,488,962 6,635,280 6,723,340 7,438,927 7,731,989 |
|
Janssen Products, L.P. v. Lupin Ltd., 12-2840 (D.N.J.) |
May 10, 2012 |
Hon. William H. Walls |
Prezista®(darunavir tablets) |
RE42,889 |
|
Helsinn Healthcare S.A. v. Dr. Reddy’s Labs., Ltd., 12-2867 (D.N.J.) |
May 11, 2012 |
Hon. Mary L. Cooper |
Aloxi®(palonosetron hydrochloride intravenous solutions) |
7,947,724 |
|
Novartis Pharma. Corp. v. Lupin Ltd., 12-0595 (D. Del.) |
May 14, 2012 |
Hon. Sue L. Robinson |
Exforge HCT®(amlodipine besylate, valsartan, and hydrochlorothiazide tablets) |
6,294,197 8,101,599 |
|
Novartis Pharma. Corp. v. Torrent Pharma. Ltd., 12-0596 (D. Del.) |
May 14, 2012 |
Hon. Sue L. Robinson |
Exforge HCT®(amlodipine besylate, valsartan, and hydrochlorothiazide tablets) |
6,294,197 8,101,599 |
|
Warner Chilcott Co., LLC v. Watson Labs., Inc., 12-2928 (D.N.J.) |
May 16, 2012 |
Hon. Joel A. Pisano |
Lo Loestrin®Fe (norethindrone acetate and ethinyl estradiol tablets) |
5,552,394 7,704,984 |
|
Allergan, Inc. v. Hi-Tech Pharmacal Co., Inc., 12-0492 (M.D.N.C.) |
May 16, 2012 |
Hon. Catherine C. Eagles |
Latisse®(bimatoprost topical solution, 0.03%) |
8,101,161 |
|
Cumberland Pharma. Inc. v. Innopharma, Inc., 12-0618 (D. Del.) |
May 17, 2012 |
Hon. Leonard P. Stark |
Acetadote®(acetylcysteine for injection) |
8,148,356 |
|
Cumberland Pharma. Inc. v. Paddock Labs., LLC, 12-0619 (D. Del.) |
May 17, 2012 |
Hon. Leonard P. Stark |
Acetadote®(acetylcysteine for injection) |
8,148,356 |
|
Cumberland Pharma. Inc. v. Mylan Institutional LLC, 12-3846 (N.D. Ill.) |
May 17, 2012 |
Hon. Rebecca R. Pallmeyer |
Acetadote®(acetylcysteine for injection) |
8,148,356 |
|
Janssen Pharma., Inc. v. Haupt Pharma., Inc., 12-3034 (D.N.J.) |
May 22, 2012 |
Hon. Stanley R. Chessler |
Ortho Tri-Cyclen®LO (norgestimate and ethinyl estradiol) |
6,214,815 |
|
Astellas US LLC v. Hospira, Inc., 12-0652 (D. Del.) |
May 23, 2012 |
Hon. Sue L. Robinson |
Adenoscan®(adenosine for injection) |
5,731,296 |
|
Auxilium Pharma., Inc. v. Watson Labs., Inc. (NV), 12-3084 (D.N.J.) |
May 23, 2012 |
Hon. Jose L. Linares |
Testim®(testosterone gel) |
7,320,968 7,608,605 7,608,606 7,608,607 7,608,608 7,608,609 7,608,610 7,935,690 8,063,029 8,178,518 |
|
Pfizer Inc. v. Sandoz Inc., 12-0654 (D. Del.) |
May 24, 2012 |
Hon. Gregory M. Sleet |
Torisel®(temsirolimus for injection) |
8,026,276 |
|
Shire Development, LLC v. Mylan Pharma., Inc., 12-1190 (M.D. Fla.) |
May 25, 2012 |
Hon. James S. Moody, Jr. |
Lialda®(mesalamine delayed release tablets) |
6,773,720 |
|
Merck Sharp & Dohme Corp. v. Sandoz Inc., 12-3289 (D.N.J.) |
May 31, 2012 |
Hon. Peter G. Sheridan |
Emend®(fosaprepitant dimeglumine for injection) |
5,691,336 5,716,942 |
|
Merck Sharp & Dohme Corp. v. Accord Healthcare, Inc. USA, 12-3324 (D.N.J.) |
June 1, 2012 |
Hon. Peter G. Sheridan |
Emend®(fosaprepitant dimeglumine for injection) |
5,691,336 5,716,942 |
|
Abbott Labs. v. Kremers Urban Pharma., Inc., 12-0703 (D. Del.) |
June 1, 2012 |
Hon. Sue L. Robinson |
Niaspan®(niacin extended release tablets) |
6,080,428 6,469,035 |
|
Medicis Pharma. Corp. v. Zydus Pharma. USA Inc., 12-0707 (D. Del.) |
June 4, 2012 |
Hon. Leonard P. Stark |
Solodyn®(minocycline HCl extended release tablets) |
5,908,838 7,790,705 7,919,483 |
|
Medicis Pharma. Corp. v. Zydus Pharma. USA Inc., 12-3368 (D. Del.) |
June 5, 2012 |
Hon. Freda L. Wolfson |
Solodyn®(minocycline HCl extended release tablets) |
5,908,838 7,790,705 7,919,483 |
|
Janssen Products, L.P. v. Teva Pharma. USA, Inc., 12-3569 (D.N.J.) |
June 13, 2012 |
Hon. William H. Walls |
Prezista®(darunavir) |
RE42,889 |
|
Janssen Products, L.P. v. Hetero Drugs, Ltd., 12-3570 (D.N.J.) |
June 13, 2012 |
Hon. William H. Walls |
Prezista®(darunavir) |
RE42,889 |
|
Bristol-Myers Squibb Co. v. Sandoz Inc., 12-0787 (D. Del.) |
June 21, 2012 |
Hon. Richard G. Andrews |
Baraclude®(entecavir tablets) |
5,206,244 |
|
Pfizer Inc. v. Anchen Pharma., Inc., 12-0808 (D. Del.) |
June 22, 2012 |
Unassigned |
Pristiq®(O-desmethylvenlafaxine succinate extended release tablets) |
6,673,838 |
|
Pfizer Inc. v. Apotex, Inc., 12-0809 (D. Del.) |
June 22, 2012 |
Unassigned |
Pristiq®(O-desmethylvenlafaxine succinate extended release tablets) |
6,673,838 |
|
Pfizer Inc. v. Breckenridge Pharmaceitucal, Inc., 12-0810 (D. Del.) |
June 22, 2012 |
Unassigned |
Pristiq®(O-desmethylvenlafaxine succinate extended release tablets) |
6,673,838 |
|
Pfizer Inc. v. Lupin Ltd., 12-0811 (D. Del.) |
June 22, 2012 |
Unassigned |
Pristiq®(O-desmethylvenlafaxine succinate extended release tablets) |
6,673,838 |
|
Pfizer Inc. v. Mylan Pharma. Inc., 12-0812 (D. Del.) |
June 22, 2012 |
Unassigned |
Pristiq®(O-desmethylvenlafaxine succinate extended release tablets) |
6,673,838 |
|
Pfizer Inc. v. Roxane Labs. Inc., 12-0813 (D. Del.) |
June 22, 2012 |
Unassigned |
Pristiq®(O-desmethylvenlafaxine succinate extended release tablets) |
6,673,838 |
|
Pfizer Inc. v. Sandoz Inc., 12-0814 (D. Del.) |
June 22, 2012 |
Unassigned |
Pristiq®(O-desmethylvenlafaxine succinate extended release tablets) |
6,673,838 |
|
Pfizer Inc. v. Teva Pharma. USA Inc., 12-0815 (D. Del.) |
June 22, 2012 |
Unassigned |
Pristiq®(O-desmethylvenlafaxine succinate extended release tablets) |
6,673,838 |
|
Pfizer Inc. v. Watson Labs. Inc.—Florida, 12-0816 (D. Del.) |
June 22, 2012 |
Unassigned |
Pristiq®(O-desmethylvenlafaxine succinate extended release tablets) |
6,673,838 |
|
Pfizer Inc. v. Wockhardt Ltd., 12-0817 (D. Del.) |
June 22, 2012 |
Unassigned |
Pristiq®(O-desmethylvenlafaxine succinate extended release tablets) |
6,673,838 |
|
Pfizer Inc. v. Zydus Pharma. USA Inc., 12-0818 (D. Del.) |
June 22, 2012 |
Unassigned |
Pristiq®(O-desmethylvenlafaxine succinate extended release tablets) |
6,673,838 |
|
Pfizer Inc. v. Sandoz Inc., 12-3880 (D.N.J.) |
June 25, 2012 |
Hon. Peter G. Sheridan |
Pristiq®(O-desmethylvenlafaxine succinate extended release tablets) |
6,673,838 |
|
Pfizer Inc. v. Zydus Pharma. USA Inc., 12-3893 (D.N.J.) |
June 25, 2012 |
Hon. Peter G. Sheridan |
Pristiq®(O-desmethylvenlafaxine succinate extended release tablets) |
6,673,838 |
|
Pfizer Inc. v. Watson Labs. Inc.—Florida, 12-61268 (S.D. Fla.) |
June 25, 2012 |
Hon. Robin S. Rosenbaum |
Pristiq®(O-desmethylvenlafaxine succinate extended release tablets) |
6,673,838 |
|
Pfizer Inc. v. Anchen Pharma., Inc., 12-5535 (C.D. Cal.) |
June 25, 2012 |
Hon. George H. King |
Pristiq®(O-desmethylvenlafaxine succinate extended release tablets) |
6,673,838 |
|
Galderma Labs. L.P. v. Actavis Mid Atlantic LLC, 12-2038 (N.D. Tex.) |
June 26, 2012 |
Hon. A. Joe Fish |
Epiduo®(adapalene and benzoyl peroxide gel) |
7,820,186 7,964,202 8,071,644 8,080,537 8,105,618 8,129,362 |
|
Pfizer Inc. v. Mylan Pharma. Inc., 12-0106 (N.D.W.V.) |
June 26, 2012 |
Hon. Irene M. Keeley |
Pristiq®(O-desmethylvenlafaxine succinate extended release tablets) |
6,673,838 |
|
Cumberland Pharma. Inc. v. Sagent Agila LLC, 12-0825 (D. Del.) |
June 26, 2012 |
Unassigned |
Acetadote®(acetylcysteine for injection) |
8,148,356 |
|
Novartis Pharma. Corp. v. Wockhardt USA LLC, 12-3967 (D.N.J.) |
June 27, 2012 |
Hon. Susan D. Wigenton |
Reclast®(zoledronic acid for injection) Zometa®(zoledronic acid for injection) |
7,932,241 8,052,987 |
|
Purdue Pharma L.P. v. Sandoz, Inc., 12-5082 (S.D.N.Y.) |
June 28, 2012 |
Unassigned |
OxyContin®(oxycodone hydrochloride extended release tablets) |
8,114,383 |
|
Purdue Pharma L.P. v. Teva Pharma. USA, Inc., 12-5083 (S.D.N.Y.) |
June 28, 2012 |
Unassigned |
OxyContin®(oxycodone hydrochloride extended release tablets) |
8,114,383 |
|
Endo Pharma. Inc. v. Noven Pharma., Inc., 12-0831 (D. Del.) |
June 29, 2012 |
Unassigned |
Lidoderm®(lidocaine transdermal) |
5,827,529 |
|
Alkermes Pharma Ireland Ltd. v. Intellipharmaceutics Corp., 12-0834 (D. Del.) |
June 29, 2012 |
Unassigned |
Focalin®XR (dexmethylphenidate hydrochloride capsules) |
6,228,398 6,730,325 |
|
Abbott Labs. v. Sandoz, Inc., 12-0836 (D. Del.) |
June 29, 2012 |
Unassigned |
Zemplar®(paricalcitol capsules) |
5,587,497 5,597,815 |
